Related Experiment Video

Updated: Jul 10, 2026

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease
04:21

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease

Published on: August 4, 2021

Adjunct pharmacotherapy in acute lung disease in children

N Kissoon1, P Skippen

  • 1Acute and Critical Care Programs, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada. nkissoon@cw.bc.ca

Minerva Pediatrica
|October 20, 2007
PubMed

Insights

Adjunctive therapies like inhaled nitric oxide, heliox, and surfactant may reduce mechanical ventilation risks in critically ill children. However, limited studies and varied conditions yield mixed results, hindering firm recommendations.

Area of Science:

  • Pediatric Critical Care Medicine
  • Respiratory Physiology
  • Neonatology

Background:

  • Mechanical ventilation is crucial for pediatric respiratory failure but carries significant risks.
  • Newer ventilation strategies aim to reduce lung injury, yet adjunctive therapies are explored to further mitigate stressors.
  • Inhaled nitric oxide, heliox, and surfactant are among therapies with theoretical benefits.

Purpose of the Study:

  • To review the evidence and potential benefits of adjunctive therapies in pediatric mechanical ventilation.
  • To assess the role of inhaled nitric oxide, heliox, and surfactant in reducing mechanical ventilation-related morbidity and mortality.
  • To identify limitations in current research and reasons for a paucity of firm recommendations.

Main Methods:

  • Review of existing literature on adjunctive therapies for mechanical ventilation in pediatric patients.
  • Analysis of physiological rationale and clinical study findings for inhaled nitric oxide, heliox, and surfactant.
  • Evaluation of study limitations, including small sample sizes and diverse pulmonary pathologies.

Main Results:

  • Inhaled nitric oxide shows promise for newborns with hypoxemic respiratory failure and pulmonary hypertension.
  • Surfactant is beneficial for respiratory distress syndrome in preterm neonates.
  • Heliox may aid in severe upper airway obstruction, but results are mixed for other conditions.

Conclusions:

  • Adjunctive therapies have demonstrated specific benefits in certain pediatric respiratory conditions.
  • Small study sizes and varied patient populations limit definitive conclusions and broad recommendations.
  • Further well-designed research is needed to establish the efficacy of these therapies across a wider range of respiratory diseases.

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation